Name: Predicase
Price: 199 USD

K-number	K120051
Device name	SODIUM CHLORIDE INHALATION SOLUTION, 3%, 7%, AND 10%, USP-4ML
Applicant	Nephron Pharmaceuticals Corp.
Product code	CAF
Device class	Class II
Decision date	Apr 20, 2012
Decision	Substantially Equivalent
Regulation	868.5630

AI Summary

AI extraction for this record is queued and will appear within 24 hours. View full FDA record →

Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?

Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.

Start free trial →

SODIUM CHLORIDE INHALATION SOLUTION, 3%, 7%, AND 10%, USP-4ML

Everything you need for a 510(k) submission. Nothing you don't.